We are committed to transparent communication, sound governance, and long-term value creation — keeping our investors informed and confident.
A track record built on three decades of industry experience, consistent performance, and steady growth in the cross-border pharmaceutical supply chain.
Established in 1995 with nearly 30 years of cross-border logistics expertise
Covering OTC, prescription drugs, dangerous drugs, and antibiotics in Hong Kong
Temperature-controlled facilities in Hong Kong for pharmaceutical storage
Monthly shipment volume exceeds 100 tons with 10-ton daily cargo capacity
Our financial stability is built on long-term client relationships, operational efficiency, and a growing presence in global pharmaceutical and healthcare trade.
| Period | Revenue | Growth |
|---|---|---|
| FY 2025 | 1,386,211 | 23.85 |
| FY 2024 | 1,820,362 | 26.15% |
| FY 2023 | 2,464,925 | 8.50% |
| FY 2022 | 2,271,827 | 42.75% |
| FY 2021 | 1,591,494 | 58.01% |
| FY 2020 | 3,789,881 | 22.83% |
| FY 2019 | 4,911,301 | 0.97% |
| FY 2018 | 4,959,402 | 0.93% |
| KEY METRIC | FY 2025 |
|---|---|
| Gross Margin (HK$) | -0.72% |
| Net Profit Margin (HK$) | -0.74% |
| TSE (HK$) | 81,023 |